Total Payments
$456,322
2024 Payments
$25,416
Companies
5
Transactions
190
Payment Breakdown by Category
Consulting$293,224 (64.3%)
Other$100,619 (22.1%)
Travel$48,077 (10.5%)
Research$12,163 (2.7%)
Food & Beverage$2,239 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $293,224 | 72 | 64.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $64,991 | 26 | 14.2% |
| Travel and Lodging | $48,077 | 46 | 10.5% |
| Honoraria | $35,628 | 9 | 7.8% |
| Unspecified | $12,163 | 2 | 2.7% |
| Food and Beverage | $2,239 | 35 | 0.5% |
Payments by Type
General
$444,159
188 transactions
Research
$12,163
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $274,954 | 65 | $0 (2024) |
| Merck Sharp & Dohme LLC | $74,671 | 66 | $0 (2024) |
| Seqirus USA Inc | $51,521 | 19 | $0 (2024) |
| GlaxoSmithKline, LLC. | $37,250 | 22 | $0 (2024) |
| SANOFI PASTEUR INC. | $17,927 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25,416 | 6 | PFIZER INC. ($12,400) |
| 2023 | $48,016 | 19 | PFIZER INC. ($34,300) |
| 2022 | $48,544 | 28 | PFIZER INTERNATIONAL LLC ($22,001) |
| 2021 | $34,282 | 16 | Merck Sharp & Dohme LLC ($13,073) |
| 2020 | $82,629 | 24 | PFIZER INC. ($51,300) |
| 2019 | $64,260 | 43 | PFIZER INTERNATIONAL LLC ($36,878) |
| 2018 | $111,139 | 30 | PFIZER INC. ($92,198) |
| 2017 | $42,036 | 24 | GlaxoSmithKline, LLC. ($20,922) |
All Payment Transactions
190 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Consulting Fee | Cash or cash equivalent | $12,400.00 | General |
| Category: VACCINES | ||||||
| 06/24/2024 | Seqirus USA Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,640.00 | General |
| 06/24/2024 | Seqirus USA Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,392.00 | General |
| 06/24/2024 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $465.00 | General |
| 05/17/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| 04/17/2024 | Merck Sharp & Dohme LLC | PNEUMOVAX 23 (Biological) | — | Cash or cash equivalent | $4,868.52 | Research |
| Study: Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients • Category: VACCINE | ||||||
| 12/18/2023 | PFIZER INC. | PREVNAR 20 (Biological) | Consulting Fee | Cash or cash equivalent | $5,425.00 | General |
| Category: VACCINES | ||||||
| 10/25/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $465.00 | General |
| 10/11/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $465.00 | General |
| 10/10/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $61.68 | General |
| 10/10/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $44.27 | General |
| 10/10/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $33.52 | General |
| 10/10/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $33.52 | General |
| 09/28/2023 | SANOFI PASTEUR INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,065.00 | General |
| 09/28/2023 | SANOFI PASTEUR INC. | — | Travel and Lodging | In-kind items and services | $11.61 | General |
| 09/28/2023 | SANOFI PASTEUR INC. | — | Travel and Lodging | In-kind items and services | $10.80 | General |
| 09/13/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $2,557.50 | General |
| 09/06/2023 | Seqirus USA Inc | FLUCELVAX QUADRIVALENT (Biological) | Consulting Fee | Cash or cash equivalent | $1,695.00 | General |
| Category: Vaccines | ||||||
| 08/24/2023 | PFIZER INC. | PREVNAR 20 (Biological) | Consulting Fee | Cash or cash equivalent | $15,750.00 | General |
| Category: VACCINES | ||||||
| 05/04/2023 | Seqirus USA Inc | FLUCELVAX QUADRIVALENT (Biological) | Consulting Fee | Cash or cash equivalent | $2,299.50 | General |
| Category: Vaccines | ||||||
| 03/27/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $930.00 | General |
| 01/06/2023 | PFIZER INC. | PREVNAR 20 (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: VACCINES | ||||||
| 01/05/2023 | PFIZER INC. | PREVNAR 20 (Biological) | Consulting Fee | Cash or cash equivalent | $9,625.00 | General |
| Category: VACCINES | ||||||
| 01/05/2023 | PFIZER INC. | PREVNAR 20 (Biological) | Consulting Fee | Cash or cash equivalent | $2,800.00 | General |
| Category: VACCINES | ||||||
| 01/04/2023 | Seqirus USA Inc | FLUCELVAX QUADRIVALENT (Biological) | Consulting Fee | Cash or cash equivalent | $2,044.00 | General |
| Category: Vaccines | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients | Merck Sharp & Dohme LLC | $4,869 | 1 |
About Dr. Stephen Pelton, MD
Dr. Stephen Pelton, MD is a Pediatrics healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1891777223.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Pelton, MD has received a total of $456,322 in payments from pharmaceutical and medical device companies, with $25,416 received in 2024. These payments were reported across 190 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($293,224).
Ad
Practice Information
- Specialty Pediatrics
- Other Specialties Pediatric Infectious Diseases
- Location Boston, MA
- Active Since 11/21/2005
- Last Updated 07/09/2014
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1891777223
Products in Payments
- PREVNAR - 13 (Biological) $120,253
- PREVNAR 20 (Biological) $76,289
- PREVNAR 13 (Biological) $29,063
- PNEUMOVAX 23 (Biological) $12,729
- MENACYW CONJUGATE VACCINE (Drug) $8,697
- FLUCELVAX QUADRIVALENT (Biological) $6,039
- V114 (Biological) $1,275
- NO PRODUCT DISCUSSED (Drug) $880.14
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Boston
Dr. R Ezekowitz, Mbch Dphl, MBCH DPHL
Pediatrics — Payments: $1.2M
Pediatrics $1.2M
Tanya Laidlaw, M.d, M.D
Pediatrics — Payments: $307,922
Pediatrics $307,922
Dr. Harald Jueppner, Md, MD
Pediatrics — Payments: $202,618
Pediatrics $202,618
Rachael Grace, Md, MD
Pediatrics — Payments: $175,958
Pediatrics $175,958
Dr. Thomas Kinane, Md, MD
Pediatrics — Payments: $175,709
Pediatrics $175,709
Courtney Hanna
Pediatrics — Payments: $149,231
Pediatrics $149,231